GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NextGen Biomed Ltd (XTAE:NXGN) » Definitions » Price-to-Funds-From-Operations

NextGen Biomed (XTAE:NXGN) Price-to-Funds-From-Operations : (As of Jun. 01, 2024)


View and export this data going back to 2000. Start your Free Trial

What is NextGen Biomed Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


NextGen Biomed (XTAE:NXGN) Business Description

Traded in Other Exchanges
N/A
Address
Azrieli Center, Round Tower 22nd Floor, Tel Aviv, ISR, 6701101
NextGen Biomed Ltd is pharmaceutical company. It manufactures medical instruments. Its products include pain-free auto-injectors, lancet devices and personal use pain alleviators. It develops and markets medical equipments. Its product line include DPS-101, which is used for treatment for psoriasis. Its other product line include DPS-101 phase II/III is in clinical trial.